Market attention is now squarely focused on February 5th, when a special shareholder meeting will be held. Investors will vote on a definitive merger agreement involving a consortium led by private ...

MARLBOROUGH - Hologic, Inc. (NASDAQ:HOLX) reported fiscal first quarter earnings that fell short of analyst expectations, with revenue of $1.05 billion missing the consensus estimate of $1.07 billion.

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) yesterday presented new research demonstrating the performance of its Genius AI ® Detection 2.0 software across diverse patient ...

Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Hologic (HOLX) came out with quarterly earnings of $1.04 per share, missing the Zacks Consensus Estimate of $1.09 per share.

We came across a bearish thesis on Hologic, Inc. on Value investing subreddit by Inevitable_Kick9706. In this article, we ...

Report highlights efforts to enhance access and equity in women's health and invest in the future with science-based environmental targets, employee development and community engagement MARLBOROUGH, ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, has completed its previously announced acquisition of Gynesonics, Inc. (Gynesonics®), a privately ...

Hologic (HOLX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...